Intrahepatic cholestasis in acute viral hepatitis: a double-blind trial with dihydroxydibutylether in comparison with placebo.
Drugs Exp Clin Res
; 13(1): 51-6, 1987.
Article
in En
| MEDLINE
| ID: mdl-3297594
ABSTRACT
The authors studied the effectiveness of a choleretic drug, dihydroxydibutylether (DHBE), 900 mg daily, in patients with acute viral hepatitis and intrahepatic cholestasis. The four-week, double-blind and placebo-controlled trial showed a more rapid return to normal bilirubin and fasting and post-prandial biliary acid values and plasma transaminases levels in the DHBE-treated group of patients.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cholagogues and Choleretics
/
Cholestasis, Intrahepatic
/
Ethers
/
Hepatitis, Viral, Human
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Drugs Exp Clin Res
Year:
1987
Document type:
Article